Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
The specific aims of this FIRCA proposal are: 1) To isolate pure endocytic
vesicles from different kidney regions (cortex, inner stripe of the outer
medulla, papilla). Vesicles purified by traditional methods are
contaminated with other membranes, and we plan to develop and use affinity-
purification techniques with specific antibodies to improve vesicle purity
while maintaining a high yield; 2) To characterize enzyme and transport
activities of the resulting endosomal preparations, including the H+-ATPase
(H-pump), Na+/H+-exchange, Ca2+ /H+-exchange, Ca2+=ATPase (Ca-pump), Cl-
channel, and different types of water channels; 3) To generate immune sera
by immunizing rabbits with preparations of highly purified endocytic
vesicles; 4) To purify particular antibodies by immunoadsorption
techniques from immune sera. A battery of antibodies, thus obtained, will
be used in immunocytochemical studies on renal tissue sections in order to
specify one or more antibodies that specifically label endocytic vesicles
in defined populations of renal cells. These antibodies will be used as
tools for the further affinity purification of vesicle populations as well
as for studies on vesicle transport pathways that are part of the parent
grant. The results will allow us to describe in more detail the molecular
and functional heterogeneity of endosomal vesicles from various tubules in
the mammalian kidney and to study their behaviour in a variety of
conditions with disturbances in salt, water, and protein reabsorption.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
G proteinadenosinetriphosphataseantibodyapical membranebasolateral membranecalciumcell population studycell typecellular polaritychlorineenzyme activityepitheliumguanine nucleotide binding proteinhydrogenimmunocytochemistryin situ hybridizationion transportkidney celllaboratory rabbitmembrane transport proteinsmicrotubulesprotein purificationprotein structure functionsodiumvesicle /vacuole
John E. Fogarty International Center for Advanced Study in the Health Sciences
CFDA Code
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
01-April-1995
Project End Date
31-March-1998
Budget Start Date
01-April-1995
Budget End Date
31-March-1996
Project Funding Information for 1995
Total Funding
$21,725
Direct Costs
$20,000
Indirect Costs
$1,725
Year
Funding IC
FY Total Cost by IC
1995
John E. Fogarty International Center for Advanced Study in the Health Sciences
$21,725
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R03TW000512-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R03TW000512-01
Patents
No Patents information available for 1R03TW000512-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R03TW000512-01
Clinical Studies
No Clinical Studies information available for 1R03TW000512-01
News and More
Related News Releases
No news release information available for 1R03TW000512-01
History
No Historical information available for 1R03TW000512-01
Similar Projects
No Similar Projects information available for 1R03TW000512-01